Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. Jointly holding's most recent trade in Aurobindo Pharma Ltd. was a Revoke of 3,750,000 Equity Shares done at an average price of Rs. 469.3 . Disclosure was reported to the exchange on Feb. 28, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. Jointly holding in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Revoke | 28 Feb 2023 | 3,750,000 | 16,726,716 (2.85%) | 0.64% | 469.3 | 1,759,687,500 | 24 Feb 2023 24 Feb 2023 |
Insider Trading | Equity Shares | Pledge Released |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Revoke | 19 Jan 2022 | 3,106,000 | 16,726,716 (2.85%) | 0.53% | 668.8 | 2,077,292,800 | 18 Jan 2022 18 Jan 2022 |
Insider Trading | Equity Shares | Pledge Released |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Revoke | 01 Dec 2021 | 15,000 | 16,726,716 (2.85%) | 0.00% | 660.3 | 9,903,750 | 30 Nov 2021 30 Nov 2021 |
Insider Trading | Equity Shares | Pledge Released |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 26 Nov 2021 | 151,000 | 16,726,716 (2.85%) | 0.03% | 651.0 | 98,293,450 | 23 Nov 2021 23 Nov 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 26 Nov 2021 | 3,750,000 | 16,726,716 (2.85%) | 0.64% | 651.0 | 2,441,062,500 | 23 Nov 2021 23 Nov 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Revoke | 26 Nov 2021 | 4,000,000 | 16,726,716 (2.85%) | 0.68% | 651.0 | 2,603,800,000 | 23 Nov 2021 23 Nov 2021 |
Insider Trading | Equity Shares | Pledge Released |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 19 Aug 2021 | 205,000 | 16,726,716 (2.85%) | 0.03% | 738.1 | 151,300,250 | 16 Aug 2021 16 Aug 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 19 Aug 2021 | 265,000 | 16,726,716 (2.85%) | 0.05% | 738.1 | 195,583,250 | 16 Aug 2021 16 Aug 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 17 Aug 2021 | 120,000 | 16,726,716 (2.85%) | 0.02% | 761.3 | 91,356,000 | 13 Aug 2021 13 Aug 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 17 Aug 2021 | 400,000 | 16,726,716 (2.85%) | 0.07% | 761.3 | 304,520,000 | 13 Aug 2021 13 Aug 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 16 Aug 2021 | 2,630,000 | 16,726,716 (2.85%) | 0.45% | 856.5 | 2,252,595,000 | 11 Aug 2021 11 Aug 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 12 Jul 2021 | 1,250,000 | 16,726,716 (2.85%) | 0.21% | 948.7 | 1,185,875,000 | 09 Jul 2021 09 Jul 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Revoke | 12 Jul 2021 | 10,000 | 16,726,716 (2.85%) | 0.00% | 951.3 | 9,512,500 | 08 Jul 2021 08 Jul 2021 |
Insider Trading | Equity Shares | Pledge Released |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 07 Jul 2021 | 2,000,000 | 16,726,716 (2.85%) | 0.34% | 1002.6 | 2,005,200,000 | 05 Jul 2021 05 Jul 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Revoke | 06 Apr 2021 | 3,600,000 | 16,726,716 (2.85%) | 0.61% | 882.2 | 3,175,920,000 | 05 Apr 2021 05 Apr 2021 |
Insider Trading | Equity Shares | Pledge Released |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 26 Mar 2021 | 300,000 | 16,726,716 (2.85%) | 0.05% | 846.2 | 253,845,000 | 23 Mar 2021 23 Mar 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 17 Feb 2021 | 3,400,000 | 16,726,716 (2.85%) | 0.58% | 932.2 | 3,169,480,000 | 15 Feb 2021 15 Feb 2021 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) (Revised) | Promoter Group | Revoke | 21 Dec 2020 | 3,090,000 | 16,726,716 (2.85%) | 0.53% | 837.8 | 2,588,647,500 | 08 Oct 2020 08 Oct 2020 |
Insider Trading | Equity Shares | Pledge Released |
| Aurobindo Pharma | Axis Clinicals Ltd., Trident Chemphar Ltd., and RPR Sons Advisors Private Ltd. (Jointly holding) | Promoter Group | Pledge | 12 Oct 2020 | 3,090,000 | 16,726,716 (2.85%) | 0.53% | 837.8 | 2,588,647,500 | 08 Oct 2020 08 Oct 2020 |
Insider Trading | Equity Shares | Pledge Released |